- Home
- SCYX vs CNTY Comparison
SCYX vs CNTY Comparison
Compare SCYX & CNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCYX | CNTY |
|---|---|---|
| Founded | 1999 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 36.0M |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SCYX | CNTY |
|---|---|---|
| Price | $3.79 | $0.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $36.33 | $2.75 |
| AVG Volume (30 Days) | ★ 284.7K | 84.2K |
| Earning Date | 11-09-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.36 | 51.31 |
| EPS | N/A | ★ N/A |
| Revenue | $257,000.00 | ★ $430,529,000.00 |
| Revenue This Year | N/A | $3.04 |
| Revenue Next Year | $977.86 | $0.09 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 10.82 |
| 52 Week Low | $0.66 | $0.74 |
| 52 Week High | $6.09 | $2.28 |
Technical Indicators
Market Signals| Indicator | SCYX | CNTY |
|---|---|---|
| Relative Strength Index (RSI) | 39.78 | 17.62 |
| Support Level | $3.53 | N/A |
| Resistance Level | $4.30 | $1.33 |
| Average True Range (ATR) | 0.23 | 0.08 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 23.92 | 12.03 |
Price Performance
Historical ComparisonAbout SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has five reportable segments based on the geographical locations in which its casinos operate; US East, US Midwest, US West, Canada, and Poland.